Items Tagged ‘BRCA1/2’

May 26th, 2015

Platinum-Based Chemotherapy Active in Metastatic Triple-Negative Breast Cancer


Platinum-based chemotherapy appears active in the treatment of metastatic triple-negative breast cancers, particularly among patients with a BRCA1/2 mutation. These findings were reported in the Journal of Clinical Oncology. Breast cancers that are not stimulated to grow from exposure to estrogen or progesterone and are HER2 (human epidermal growth factor receptor)-negative are called triple-negative breast […]

View full entry

Tags: BRCA1/2, Breast Cancer, cisplatin, Metastatic Breast Cancer, News, Platinol, platinum based chemotherapy, triple negative